← Back to Search

Behavioral Intervention

Condition B: Online one-on-one peer navigation (SOC + PrEP4T) for Human Immunodeficiency Virus Infection (TOGETHR Trial)

N/A

Waitlist Available

Research Sponsored by Fenway Community Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Is HIV-uninfected

Age 18 or over

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

TOGETHR Trial Summary

This trial is studying ways to increase engagement in HIV prevention services, specifically for transgender masculine and gender diverse people who have sex with men. The trial will compare different interventions, including one-on-one support and

Who is the study for?

This trial is for transgender masculine and gender diverse individuals who have sex with men, at increased risk of HIV. Participants should be interested in prevention services but haven't yet engaged effectively. Specific eligibility details are not provided, so it's assumed that participants must meet certain health criteria to join.Check my eligibility

What is being tested?

The study tests the effectiveness of digital peer-support interventions on PrEP engagement for HIV prevention. It compares standard HIV prevention info with one-on-one (PrEP4T) and group-based (LS4TM) support interventions, individually or combined, to see which method increases PrEP uptake and persistence among participants.See study design

What are the potential side effects?

Since this trial focuses on behavioral interventions rather than medications, traditional side effects like those seen with drugs may not apply. However, participants might experience emotional or psychological impacts from discussing sensitive topics related to their lifestyle and health.

TOGETHR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have HIV.

Select...

I am 18 years old or older.

Select...

I was assigned female at birth.

TOGETHR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PrEP uptake

Secondary outcome measures

PrEP adherence and persistence

TOGETHR Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Condition D: Peer-delivered and group-based intervention (SOC + PrEP4T + LS4TM)Experimental Treatment2 Interventions

Both PrEP4T and LS4TM will be delivered to participants. Group D will receive 21 hours of content: 6 2-hour LS4TM sessions and 6 1.5-hour PrEP4T sessions. Group D participants may not receive both interventions simultaneously within 6 weeks.

Group II: Condition C: Online peer-delivered small group-based behavioral intervention (SOC + LS4TM)Experimental Treatment1 Intervention

LS4TM is a theory-based peer-delivered small group-based behavioral intervention. The LS4TM manualized intervention is comprised of 9 hours of content: 6 2-hour small-group sessions with up to 12 participants per group delivered weekly for 6 weeks. Participants will also receive access to the SOC materials.

Group III: Condition B: Online one-on-one peer navigation (SOC + PrEP4T)Experimental Treatment1 Intervention

PrEP4T is an individualized TMSM-specific intervention consisting of online one-on-one sessions between a peer and a participant. PrEP4T has 9 hours of content: 6 1.5-hour sessions conducted weekly for 6 weeks. Participants will also receive access to the SOC materials.

Group IV: Condition A: Standard of Care (SOC)Active Control1 Intervention

SOC will include linkage to the CDC's HIV Prevention Services Locator, a US directory of HIV testing and PrEP services. A Digital Library of HIV prevention, sexual health, and anti-stigma materials (written and video media) will be provided. This content is curated from CDC, Gate Trans Men & HIV Project, UCSF Center for Excellence in Trans Health, and National LGBTQIA+ Health Education Center, among other sources.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,334 Total Patients Enrolled

Fenway Community HealthLead Sponsor

34 Previous Clinical Trials

5,831,369 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers actively seeking participants for this study at the moment?

"According to the information available on clinicaltrials.gov, this specific clinical trial is not actively enrolling participants. The study was initially posted on January 1st, 2024 and its most recent update occurred on December 13th, 2023. Although this particular study has concluded recruitment, there are currently a total of 524 other studies that are seeking eligible patients for participation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction

Sari Reisner, ScD 2024. "Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06182280.

All > Prep